What is the goal of treating indolent B-cell NHL?

The goal of any indolent B-cell non-Hodgkin lymphoma (NHL) treatment is to lower or get rid of the NHL cells in the blood and the bone marrow. Any treatment plan you and your doctor might choose will be a treatment that has worked when tested in some patients. But not all patients are the same, and that is why some treatments that work for some patients may not work for others. TREANDA is specifically indicated for use in patients who do not respond to rituximab or a rituximab-containing treatment.

What are the treatment options for NHL?

There are many choices for treating NHL. If one kind of treatment does not work, or if it works for a while and then your disease comes back, your doctor may change to a different treatment.

The treatment choices may include:

Chemotherapy: A cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells, or by stopping them from increasing in number.

Biologic therapy: A type of treatment that works with your immune system. Monoclonal antibody therapy is one type of biologic therapy used to treat NHL. It can help the immune system kill lymphoma cells.

Radiation therapy: A treatment that uses high-energy X-rays or other types of radiation to kill cancer cells and keep them from growing.

> Next page: What is TREANDA?